Nitric oxide-dependent apoptosis in ovarian carcinoma cell lines

Gynecologic Oncology

Volumn 82, Issue 1, 2001, Pages 172-176

  Rieder, Josef ^a   Jahnke, Rolf ^b   Schloesser, Michaela ^b   Seibel, Maja ^b   Czechowski, Monika ^b   Marth, Christian ^a   Hoffmann, Georg ^b  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Apoptosis; Nitric oxide; Ovarian carcinoma

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 1BETA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL SURVIVAL; HUMAN; HUMAN CELL; IMMUNOSTIMULATION; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0034938181     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6242     Document Type: Article

References (22)

1. Nitric oxide synthase: Expression and expressional control of the three isoforms
2. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation
3. Nitric oxide synthase activity in human breast cancer
4. Nitric oxide: Cytotoxicity versus cytoprotection - How, why, when, and where?
5. Frequent nitric oxide synthase-2 expression in human colon adenomas: Implication for tumor angiogenesis and colon cancer progression
6. Roles of nitric oxide in tumor growth
7. Antitumor activity of a novel glyco-nitric oxide conjugate in ovarian carcinoma
8. Molecular mechanisms underlying IFN-gamma-mediated tumor growth inhibition induced during tumor immunotherapy with rIL-12
9. Nitric oxide sensitizes ovarian tumor cells to Fas induced apoptosis
10. Different patterns of inducible nitric oxide synthase gene expression in ovarian carcinoma cell lines
11. Induction of inducible nitric oxide synthase is an essential part of tumor necrosis factor-alpha-induced apoptosis in MCF-7 and other epithelial tumor cells
12. Therapy of human pancreatic carcinoma implants by irinoteclan and the oral immunomodulator JBT 3002 is associated with enhanced expression of inducible nitric oxide synthase in tumor-infiltrating macrophages
13. Role of nitric oxide in pancreatic tumor growth: In vivo and in vitro studies
14. Human colorectal adenocarcinoma cells: Differential nitric oxide synthesis determines their ability to aggregate platelets
15. Cisplatin-based interferon gamma gene therapy of urine ovarian carcinoma
16. Analysis of the cytokine-stimulated human inducible nitric oxide synthase (iNOS) gene: Characterization of differences between human and mouse iNOS promoters
17. Nitric oxide synthase activity in human breast cancer
18. Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature
19. Nitric oxide modulates the expression of monocyte chemoattractant protein I in cultured human endothelial cells
20. Interferon-gamma in the first-line therapy of ovarian cancer: A randomized phase III trial
21. Interferon-γ and tumor necrosis factor-α induce synergistic cytolytic effects in ovarian cancer cell lines: Roles of the TR60 and TR80 tumor necrosis factor receptors
22. IL-2 enhances standard IFN-γ/LPS activation of macrophage cytotoxicity to human ovarian carcinoma in vitro: A potential for adoptive cellular immunotherapy